TrialLancet (London, England)2014

Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial.

Kevin Fitzgerald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.